IDSA has been alerted to a hoax in which an e-mail appears to have been sent by IDSA’s president on the topic of Lyme disease and mental health. If you receive an e-mail like this, please delete it immediately. The hoax is connected to a website that claims to have been endorsed by IDSA. This is a hoax, and IDSA is investigating the matter and will take appropriate steps.
Monthly archives for May, 2010
For Immediate Release: May 14, 2010
Media Inquiries: Shelly Burgess, 301-796-4651, firstname.lastname@example.org
Consumer Inquiries: 888-INFO-FDA
The U.S. Food and Drug Administration today revised its recommendations for rotavirus vaccines for the prevention of the disease in infants and has determined that it is appropriate for clinicians and health care professionals to resume the use of Rotarix and to continue the use of RotaTeq.
The agency reached its decision based on a careful evaluation of information from laboratory results from the manufacturers and the FDA’s own laboratories, a thorough review of the scientific literature, and input from scientific and public health experts, including members of the FDA’s Vaccines and Related Biological Products Advisory Committee that convened on May 7, 2010 to discuss these vaccines. Read More »